THE PRODUCTION OF MONOCLONAL ANTIBODIES TO TETRASACCHARIDE - SYNTHETIC ANALOGUE OF THE CAPSULAR POLYSACCHARIDE OF STREPTOCOCCUS PNEUMONIAE OF SEROTYPE 14 AND THEIR IMMUNOCHEMICAL CHARACTERIZATION

Cover Page


Cite item

Full Text

Abstract

Aim. Production of monoclonal antibodies (mAb) to synthetic tetrasaccharide - repeating unit of the capsular polysaccharide (CP) of Streptococcus pneumoniae serotype 14 and their immunochemical characterization. Materials and methods. In order to generate the hybridoma producing mAb, mice were immunized with synthetic tetrasaccharide conjugated with bovine serum albumin (BSA) with following hybridization of B lymphocytes with mouse myeloma cells. Antibodies were obtained in vitro andin vivo. Immunochemical characterization of mAb to tetrasaccharide was carried out using a variety of ELISA options. Results. For the first time obtained mouse hybridoma, producing IgM to tetrasacchride. The IgM titer of anti-tetrasacharide antibodies in supernatants of clones and in the ascitic fluid of mice in ELISA detected by biotinylated tetrasaccharide and synthetic CP adsorbed on the solid phase was higher compared to the use of bacterial CP as well cover antigen. In the reaction of inhibition of the ELISA, the mAb recognized the corresponding carbohydrate epitopes of the bacterial CP of S. pneumoniae serotype 14 dissolved in the liquid phase better than tetrasaccharide ligand and synthetic CP. Conclusion. To detect mAb to tetrasaccharide in ELISA preferably to use synthetic analogues of the CP as solid phase antigens. The obtained mAb to tetrasaccharide can be used to determine the representation of the protective tetrasaccharide epitope of CP in the development of pneumococcal vaccines.

About the authors

I. V. Yakovleva

Mechnikov Reseach Institute of Vaccines and Sera

Author for correspondence.
Email: noemail@neicon.ru
Russian Federation

E. A. Kurbatova

Mechnikov Reseach Institute of Vaccines and Sera

Email: noemail@neicon.ru
Russian Federation

E. A. Akhmatova

Zelinsky Institute of Organic Chemistry

Email: noemail@neicon.ru
Russian Federation

E. V. Sukhova

Zelinsky Institute of Organic Chemistry

Email: noemail@neicon.ru
Russian Federation

D. V. Yashunsky

Zelinsky Institute of Organic Chemistry

Email: noemail@neicon.ru
Russian Federation

Yu. E. Tsvetkov

Zelinsky Institute of Organic Chemistry

Email: noemail@neicon.ru
Russian Federation

N. E. Nifantiev

Zelinsky Institute of Organic Chemistry

Email: noemail@neicon.ru
Russian Federation

V. V. Sviridov

Mechnikov Reseach Institute of Vaccines and Sera

Email: noemail@neicon.ru
Russian Federation

References

  1. Ванеева Н.П., Ястребова Н.Е. Специфический иммунный ответ к отдельным капсульным полисахаридам Streptococcus pneumoniae у здоровых доноров и лиц, вакцинированных пневмококковыми вакцинами. Журн. микробиол. 2015, 5: 20-26.
  2. Генинг М.Л., Курбатова Е.А., Цветков Ю.Е., Нифантьев Н.Э. Разработка подходов к созданию углеводной конъюгированной вакцины третьего поколения против Streptococcus pneumoniae: поиск оптимальных олигосахаридных лигандов. Усп. хим. 2015, 84: 1100-1113.
  3. Методические рекомендации по получению гибридом-продуцентов моноклональных антител к бактериальным антигенам. Утверждены 29.11. 85 г. МЗ СССР.
  4. Сухова Е.В., Яшунский Д.В., Цветков Ю.Е. и др. Синтез олигосахаридных фрагментов капсульного полисахарида Streptococcus pneumoniae тип 14 и их неогликоконъюгатов с бычьим сывороточным альбумином. Известия АН. Серия химическая. 2014, 2: 511-521.
  5. Харит С.М. Пневмококковые вакцины. В кн.: Вакцины и вакцинация: национальное руководство. Под ред. В.В.Зверева, Б.Ф.Семенова, Р.М.Хаитова. М., ГОЭТАР-Медиа, 2011.
  6. Akhmatova N.K., Kurbatova E.A., Akhmatov E.A. et al. The effect of a BSA conjugate of a synthetic hexasaccharide related to the fragment of capsular polysaccharide of Streptococcus pneumoniae type 14 on the activation of innate and adaptive immune responses. Front. Immunol. 2016, 7: 1-11.
  7. Ananikov V.P., Eremin D.B., Yakukhnov S.A. et al. Organic and hybrid systems: from science to practice. Mendeleev Commun. 2017, 27: 425-438.
  8. Ananikov V.P., Galkin K.I., Egorov M.P. et al. Challenges in the development of organic and hybrid molecular systems. Mendeleev Commun. 2016, 26: 365-374.
  9. Broecker F., Anish C., Seeberger P.H. Generation of monoclonal antibodies against defined oligosaccharide antigens. Methods Mol. Biol. 2015, 1331: 57-80.
  10. Jansen W.T., Snippe H. Short-chain oligosaccharide protein conjugates as experimental pneumococcal vaccines. Indian J. Med. Res. 2004, 119 (Suppl): 7-12.
  11. Kochetkov N.K., Nifant'ev N.E., Backinowsky L.V. Synthesis of the capsular polysaccharide of Streptococcus pneumoniae type14. Tetrahedron. 1987, 43 (13): 3109-3121.
  12. Kurbatova E.A., Akhmatova N.K., Akhmatova E.A. et al. Neoglycoconjugate of tetrasaccharide representing one repeating unit of the Streptococcus pneumoniae type 14 capsular polysaccharide induces the production of opsonizing IgG1 antibodies and possesses the highest protective activity as compared to hexa- and octasaccharide conjugates. Front. Immunol. 2017, 8: 1-13.
  13. Reimer K.B., Gidney M.A., Bundle D.R., Pinto B.M. Immunochemical characterization of polyclonal and monoclonal Streptococcus group A antibodies by chemically defined glycoconjugates and synthetic oligosaccharides. Carbohydr Res. 1992, 232(1): 131-142.
  14. Safari D., Dekker H.A., Joosten A.F. Identification of the smallest structure capable of evoking opsonophagocytic antibodies against S. pneumoniae type 14. Infect. Immun. 2008, 76 : 4615-4623.
  15. Song J.Y., Moseley M.A., Burton R.L., Nahm M.H. Pneumococcal vaccine and opsonic pneumococcal antibody. J. Infect. Chemother. 2013, 3: 412-425.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Yakovleva I.V., Kurbatova E.A., Akhmatova E.A., Sukhova E.V., Yashunsky D.V., Tsvetkov Y.E., Nifantiev N.E., Sviridov V.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies